Clinical Trials Directory

Trials / Terminated

TerminatedNCT04000334

Early Transcranial Doppler Goal Directed Therapy After Cardiac Arrest: a Pilot Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypoxic-ischaemic brain injury (HIBI) is the main cause of death in patients who are comatose after resuscitation from cardiac arrest. Current guidelines recommend to target a mean arterial pressure (MAP) above 65 mmHg to achieve an adequate organ perfusion. Moreover, after cardiac arrest, cerebral autoregulation is dysregulated and cerebral blood flow (CBF) depends on the MAP. A higher blood pressure target could improve cerebral perfusion and HIBI. Transcranial Doppler (TCD) is a non-invasive method to study CBF and its variations induced by MAP. The aim of this study is to test the feasibility of an early-goal directed hemodynamic management with TCD during the first 12 hours after return of spontaneous circulation (ROSC).

Conditions

Interventions

TypeNameDescription
OTHERMAP increased to optimize cerebral blood flowMAP will be increased to 90-100 mmHg with norepinephrine. If TCD is still abnormal with a MAP of 90-100 mmHg, MAP will be increased to 100-110 mmHg. At each step, all CBF determinants will be recorded as well as cardiac output and Veinous jugular oxygen saturation (SvjO2). When TCD is normalized with no complications, MAP will be maintained at 90-100 or 100-110 mmHg during 24 hours.
OTHERMAP between 65 and 85 mmHgMAP will be maintained between 65-85 mmHg, using a norepinephrine infusion as needed.

Timeline

Start date
2020-07-29
Primary completion
2023-07-08
Completion
2023-07-08
First posted
2019-06-27
Last updated
2025-05-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04000334. Inclusion in this directory is not an endorsement.